Currently submitted to: JMIR Cancer
Date Submitted: Nov 8, 2025
Open Peer Review Period: Nov 10, 2025 - Jan 5, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Predictors Of Telehealth Use Among Cancer Survivors: Retrospective Study
ABSTRACT
Background:
As the number of cancer survivors continues to grow, optimizing long-term survivorship care models has become increasingly important. Telehealth has the potential to improve access to healthcare for survivors; however, studies evaluating telehealth in this population remain limited. Additionally, concerns persist regarding equity in technology access and digital literacy.
Objective:
This study aimed to examine demographic factors and patient attitudes influencing telehealth use among cancer survivors compared to the general population.
Methods:
Adult participants were identified from the nationally representative database Health Information National Trends Survey 6 (HINTS 6). Multivariate logistic regression was used to calculate the predictors of telehealth use among cancer survivors. Chi-square tests compared the prevalence of reported reasons of not using telehealth in the last 12 months between cancer survivors and the general population.
Results:
A total of 239,557,883 individuals were included in this study, 7.7% of whom are cancer survivors. Older age was associated with lower telehealth use (adjusted odds ratio [aOR]=0.11; 95% CI: 0.02–0.59 for patients aged ≥65, compared to those under 40 years old). Higher education (aOR=2.55; 95% CI: 1.24–5.27) and heart disease history (aOR=2.52; 95% CI: 1.20–5.28) were associated with increased telehealth use. Employed (aOR=0.46; 95%CI: 0.22-0.97) and retired (aOR=0.37; 95%CI: 0.18-0.77) cancer survivors were less likely to use telehealth than unemployed individuals. Of the non-users, over 60% reported that telehealth options were not offered, and 80% preferred in-person visits. Technical issues and privacy concerns were not major factors in utilizing telehealth.
Conclusions:
Despite greater telehealth use among cancer survivors, a negative association between older age and telemedicine utilization persists. Efforts should focus on improving access for older cancer survivors and addressing employment-related factors, patient attitudes, and telehealth availability. Future studies should explore personalized approaches to enhance cancer survivors’ healthcare experiences.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.